To the full analysis
PROCEPT BioRobotics stock: growth
PRCTPROCEPT BioRobotics reported $308.05M in revenue for fiscal 2025, up 37.2% on the prior year, up 109% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
91.9%
per year from 2019 to 2025, per share 76.5%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2019 | |
|---|---|---|
| Revenue | 109.0% | 91.9% |
| Revenue per share | 90.7% | 76.5% |
| Earnings | no data | no data |
| Earnings per share | no data | no data |
| Free cash flow | no data | no data |
| Free cash flow per share | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2019 | $6.17M | −$41.98M | −$51.43M |
| 2020 | $7.72M | −$53.02M | −$48.58M |
| 2021 | $34.47M | −$59.85M | −$57.93M |
| 2022 | $75.01M | −$87.15M | −$83.04M |
| 2023 | $136.19M | −$105.9M | −$133.21M |
| 2024 | $224.5M | −$91.41M | −$103.62M |
| 2025 | $308.05M | −$95.57M | −$58.34M |
Revenue by region
Where PROCEPT BioRobotics Corporation generates its revenue.
- United States$270.4M88%
- Outside the US$37.7M12%
The company split earlier years differently. A history would not be comparable, so only 2025 is shown.
Figures as a table
| 2025 | Share 2025 | |
|---|---|---|
| United States | $270.38M | 87.8% |
| Outside the US | $37.68M | 12.2% |
| Total revenue | $308.05M | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 8 Nov 2024)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.